Digital health startup Transcarent takes Accolade private in $621 million deal

Glen Tullman, chairman and chief executive officer at Livongo Health Inc., speaks during the 2015 Bloomberg Technology Conference in San Francisco, California, U.S., on Tuesday, June 16, 2015. Digital health startup Transcarent on Tuesday announced it completed its acquisition of Accolade in a deal valued at roughly $621 million. Transcarent first announced the acquisition in January, and the company said it has received all necessary shareholder and regulatory approvals to carry out the transaction. Accolade shareholders received $7.03 per share in cash, and its common stock will no longer trade on the Nasdaq, according to a release. "Adding Accolade's people and capabilities will significantly enhance our existing offerings," Transcarent CEO Glen Tullman said in a statement. "We're creating an entirely new way to experience health and care. We are truly better together." Transcarent offers at-risk pricing models to self-insured employers to help their workers quickly access care ... Read full article.